Marginal Effect of Maturity on Utilization Measures (P Value) | ||
---|---|---|
Intermediate-Stage Transformation | Late-Stage Transformation | |
Diabetes Mellitus | ||
Total utilization* | ||
Average across comorbidity statuses | 0.040 (.407) | 0.079 (.151) |
0 Comorbidities | 0.066 (.272) | 0.095 (.115) |
1 Comorbidity | −0.011 (.876) | 0.030 (.679) |
≥2 Comorbidities | −0.026 (.752) | 0.083 (.613) |
Number of prescriptions* | ||
Average across comorbidity statuses | 0.028 (.374) | 0.039 (.444) |
0 Comorbidities | 0.051 (.230) | 0.061 (.225) |
1 Comorbidity | −0.028 (.511) | −0.009 (.904) |
≥2 Comorbidities | 0.003 (.959) | −0.009 (.922) |
Number of outpatient visits* | ||
Average across comorbidity statuses | −0.078 (.231) | −0.151 (.020) |
0 Comorbidities | −0.047 (.560) | −0.147 (.075) |
1 Comorbidity | −0.130 (.030) | −0.172 (.004) |
≥2 Comorbidities | −0.184 (.005) | −0.124 (.172) |
≥1 Inpatient admission† | ||
Average across comorbidity statuses | 0.007 (.600) | 0.002 (.854) |
0 Comorbidities | 0.000 (.992) | −0.005 (.620) |
1 Comorbidity | 0.011 (.718) | 0.007 (.821) |
≥2 Comorbidities | 0.061 (.248) | 0.066 (.297) |
≥1 Emergency department visit† | ||
Average across comorbidity statuses | 0.012 (.498) | 0.024 (.239) |
0 Comorbidities | 0.014 (.362) | 0.014 (.401) |
1 Comorbidity | 0.036 (.431) | 0.064 (.179) |
≥2 Comorbidities | −0.074 (.126) | −0.009 (.855) |
Cardiovascular disease | ||
Total utilization* | ||
Average across comorbidity statuses | −0.035 (.607) | −0.072 (.505) |
0 Comorbidities | −0.076 (.349) | −0.175 (.107) |
1 Comorbidity | 0.055 (.510) | 0.159 (.294) |
≥2 Comorbidities | −0.111 (.424) | −0.256 (.147) |
Number of prescriptions* | ||
Average across comorbidity statuses | −0.046 (.287) | −0.047 (.543) |
0 Comorbidities | −0.083 (.234) | −0.099 (.309) |
1 Comorbidity | 0.040 (.388) | 0.047 (.579) |
≥2 Comorbidities | −0.125 (.141) | −0.089 (.401) |
Number of outpatient visits* | ||
Average across comorbidity statuses | −0.167 (.002) | −0.201 (.010) |
0 Comorbidities | −0.198 (.004) | −0.340 (.000) |
1 Comorbidity | −0.055 (.530) | 0.029 (.835) |
≥2 Comorbidities | −0.342 (.004) | −0.261 (.024) |
≥1 Inpatient admission† | ||
Average across comorbidity statuses | 0.029 (.362) | −0.001 (.985) |
0 Comorbidities | 0.014 (.532) | −0.021 (.377) |
1 Comorbidity | 0.064 (.177) | 0.073 (.199) |
≥2 Comorbidities | −0.001 (.992) | −0.105 (.258) |
Cardiovascular disease | ||
≥1 Emergency department visit† | ||
Average across comorbidity statuses | 0.009 (.802) | −0.012 (.752) |
0 Comorbidities | −0.038 (.287) | −0.104 (.008) |
1 Comorbidity | 0.062 (.143) | 0.100 (.057) |
≥2 Comorbidities | 0.061 (.578) | 0.066 (.520) |
↵* Approximate percentage change (0.10 = 10%) in outcome variable when clinic moves from early stage to intermediate- or late-stage transformation.
↵† Estimated percentage-point change (0.10 = 10 percentage points) in the probability of outcome when a clinic moves from early stage to intermediate- or late-stage transformation.